Published in PLoS One on April 28, 2010
Targeting the TGFβ signalling pathway in disease. Nat Rev Drug Discov (2012) 4.30
Targeting miRNAs involved in cancer stem cell and EMT regulation: An emerging concept in overcoming drug resistance. Drug Resist Updat (2010) 1.98
Epithelial-mesenchymal transition and cancer stem cells: a dangerously dynamic duo in breast cancer progression. Breast Cancer Res (2011) 1.96
Deconstructing the mechanisms and consequences of TGF-β-induced EMT during cancer progression. Cell Tissue Res (2011) 1.53
Doxorubicin eliminates myeloid-derived suppressor cells and enhances the efficacy of adoptive T-cell transfer in breast cancer. Cancer Res (2013) 1.42
Hypoxia-inducing factors as master regulators of stemness properties and altered metabolism of cancer- and metastasis-initiating cells. J Cell Mol Med (2013) 1.38
Transcription factors that mediate epithelial-mesenchymal transition lead to multidrug resistance by upregulating ABC transporters. Cell Death Dis (2011) 1.34
Phase I study of GC1008 (fresolimumab): a human anti-transforming growth factor-beta (TGFβ) monoclonal antibody in patients with advanced malignant melanoma or renal cell carcinoma. PLoS One (2014) 1.26
Role of microRNAs in the regulation of breast cancer stem cells. J Mammary Gland Biol Neoplasia (2012) 1.25
FOXM1 mediates Dox resistance in breast cancer by enhancing DNA repair. Carcinogenesis (2012) 1.22
Therapeutic targets for bone metastases in breast cancer. Breast Cancer Res (2011) 1.16
Pathways to breast cancer recurrence. ISRN Oncol (2013) 1.15
Antitumor activity of Noscapine in combination with Doxorubicin in triple negative breast cancer. PLoS One (2011) 1.07
Significance of PELP1/HDAC2/miR-200 regulatory network in EMT and metastasis of breast cancer. Oncogene (2013) 1.06
Significance of PELP1 in ER-negative breast cancer metastasis. Mol Cancer Res (2011) 1.02
Chemotherapy-enhanced inflammation may lead to the failure of therapy and metastasis. Onco Targets Ther (2014) 0.93
Two faces of TGF-beta1 in breast cancer. Mediators Inflamm (2014) 0.92
Schisandrin B attenuates cancer invasion and metastasis via inhibiting epithelial-mesenchymal transition. PLoS One (2012) 0.91
Doxorubicin-enriched, ALDH(br) mouse breast cancer stem cells are treatable to oncolytic herpes simplex virus type 1. BMC Cancer (2012) 0.90
N1-guanyl-1,7-diaminoheptane sensitizes bladder cancer cells to doxorubicin by preventing epithelial-mesenchymal transition through inhibition of eukaryotic translation initiation factor 5A2 activation. Cancer Sci (2014) 0.87
Attenuation of TGF-β signaling supports tumor progression of a mesenchymal-like mammary tumor cell line in a syngeneic murine model. Cancer Lett (2013) 0.86
PATZ1 acts as a tumor suppressor in thyroid cancer via targeting p53-dependent genes involved in EMT and cell migration. Oncotarget (2015) 0.86
Vincristine enhances amoeboid-like motility via GEF-H1/RhoA/ROCK/Myosin light chain signaling in MKN45 cells. BMC Cancer (2012) 0.84
Cancer stem cells and side population cells in breast cancer and metastasis. Cancers (Basel) (2011) 0.84
Blockade of Autocrine TGF-β Signaling Inhibits Stem Cell Phenotype, Survival, and Metastasis of Murine Breast Cancer Cells. J Stem Cell Res Ther (2012) 0.84
Sheep, wolf, or werewolf: cancer stem cells and the epithelial-to-mesenchymal transition. Cancer Lett (2013) 0.83
Steroid Receptor Coactivator-3 (SRC-3/AIB1) as a Novel Therapeutic Target in Triple Negative Breast Cancer and Its Inhibition with a Phospho-Bufalin Prodrug. PLoS One (2015) 0.82
P53 is required for Doxorubicin-induced apoptosis via the TGF-beta signaling pathway in osteosarcoma-derived cells. Am J Cancer Res (2015) 0.81
Isolation and characterization of a metastatic hybrid cell line generated by ER negative and ER positive breast cancer cells in mouse bone marrow. PLoS One (2011) 0.81
Identifying and targeting tumor-initiating cells in the treatment of breast cancer. Endocr Relat Cancer (2015) 0.81
A mechanism linking Id2-TGFβ crosstalk to reversible adaptive plasticity in neuroblastoma. PLoS One (2013) 0.80
Chemotherapeutic Targeting of the Transforming Growth Factor-β Pathway in Breast Cancers. Breast Cancer Manag (2015) 0.79
A novel engineered VEGF blocker with an excellent pharmacokinetic profile and robust anti-tumor activity. BMC Cancer (2015) 0.78
Cationicity-enhanced analogues of the antimicrobial peptides, AcrAP1 and AcrAP2, from the venom of the scorpion, Androctonus crassicauda, display potent growth modulation effects on human cancer cell lines. Int J Biol Sci (2014) 0.78
Rapid Extensive Recurrence of Triple Negative Breast Cancer: Are Both Therapy and Cancer Biology the Culprit? J Clin Med Res (2015) 0.77
Doxorubicin resistant cancer cells activate myeloid-derived suppressor cells by releasing PGE2. Sci Rep (2016) 0.77
Enhancer of rudimentary homolog regulates DNA damage response in hepatocellular carcinoma. Sci Rep (2015) 0.77
Targeting the cancer-associated fibroblasts as a treatment in triple-negative breast cancer. Oncotarget (2016) 0.76
Doxorubicin-mediated bone loss in breast cancer bone metastases is driven by an interplay between oxidative stress and induction of TGFβ. PLoS One (2013) 0.76
CDK4 inhibition and doxorubicin mediate breast cancer cell apoptosis through Smad3 and survivin. Cancer Biol Ther (2014) 0.75
Chemotherapy resistance and metastasis-promoting effects of thyroid hormone in hepatocarcinoma cells are mediated by suppression of FoxO1 and Bim pathway. Cell Death Dis (2016) 0.75
Topical and systemic immunoreaction triggered by intravesical chemotherapy in an N-butyl-N-(4-hydroxybutyl) nitorosamine induced bladder cancer mouse model. PLoS One (2017) 0.75
DAFODIL: A novel liposome-encapsulated synergistic combination of doxorubicin and 5FU for low dose chemotherapy. J Control Release (2016) 0.75
Molecular Effects of Doxorubicin on Choline Metabolism in Breast Cancer. Neoplasia (2017) 0.75
The four-transmembrane protein MAL2 and tumor protein D52 (TPD52) are highly expressed in colorectal cancer and correlated with poor prognosis. PLoS One (2017) 0.75
Global cancer statistics, 2002. CA Cancer J Clin (2005) 119.22
The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell (2008) 46.08
Molecular definition of breast tumor heterogeneity. Cancer Cell (2007) 12.67
Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS One (2008) 8.97
Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature. Cancer Res (2009) 7.98
TGF-beta-induced epithelial to mesenchymal transition. Cell Res (2009) 7.88
A pooled analysis of bone marrow micrometastasis in breast cancer. N Engl J Med (2005) 6.86
Sca-1(pos) cells in the mouse mammary gland represent an enriched progenitor cell population. Dev Biol (2002) 5.74
Phase III trial of doxorubicin, paclitaxel, and the combination of doxorubicin and paclitaxel as front-line chemotherapy for metastatic breast cancer: an intergroup trial (E1193). J Clin Oncol (2003) 4.07
Development of TGF-beta signalling inhibitors for cancer therapy. Nat Rev Drug Discov (2004) 3.47
TGF-beta switches from tumor suppressor to prometastatic factor in a model of breast cancer progression. J Clin Invest (2003) 3.01
Mammosphere culture of metastatic breast cancer cells enriches for tumorigenic breast cancer cells. Breast Cancer Res (2008) 2.96
The epithelial-to-mesenchymal transition and cancer stem cells: a coalition against cancer therapies. J Mammary Gland Biol Neoplasia (2009) 2.60
Inhibition of TGF-beta with neutralizing antibodies prevents radiation-induced acceleration of metastatic cancer progression. J Clin Invest (2007) 2.52
ABC transporters, drug resistance, and cancer stem cells. J Mammary Gland Biol Neoplasia (2009) 2.43
Immunohistochemical staining for transforming growth factor beta 1 associates with disease progression in human breast cancer. Cancer Res (1992) 2.29
Immunocytochemical localization of secreted transforming growth factor-beta 1 to the advancing edges of primary tumors and to lymph node metastases of human mammary carcinoma. Am J Pathol (1993) 2.16
Survival of mammary stem cells in suspension culture: implications for stem cell biology and neoplasia. J Mammary Gland Biol Neoplasia (2005) 2.13
Mesenchyme to epithelium transition during development of the mammalian kidney tubule. Acta Anat (Basel) (1996) 2.07
Cooperation between snail and LEF-1 transcription factors is essential for TGF-beta1-induced epithelial-mesenchymal transition. Mol Biol Cell (2006) 2.06
Inhibition of growth and metastasis of mouse mammary carcinoma by selective inhibitor of transforming growth factor-beta type I receptor kinase in vivo. Clin Cancer Res (2006) 2.01
New insights of epithelial-mesenchymal transition in cancer metastasis. Acta Biochim Biophys Sin (Shanghai) (2008) 1.94
Conditional overexpression of active transforming growth factor beta1 in vivo accelerates metastases of transgenic mammary tumors. Cancer Res (2004) 1.84
Inhibition of pulmonary and skeletal metastasis by a transforming growth factor-beta type I receptor kinase inhibitor. Cancer Res (2006) 1.82
Activated type I TGFbeta receptor kinase enhances the survival of mammary epithelial cells and accelerates tumor progression. Oncogene (2005) 1.81
A novel small-molecule inhibitor of transforming growth factor beta type I receptor kinase (SM16) inhibits murine mesothelioma tumor growth in vivo and prevents tumor recurrence after surgical resection. Cancer Res (2007) 1.78
Actions of bisphosphonate on bone metastasis in animal models of breast carcinoma. Cancer (2000) 1.78
Inhibition of TGFbeta signaling in cancer therapy. Curr Opin Genet Dev (2005) 1.78
Cancer stem cells in breast: current opinion and future challenges. Pathobiology (2008) 1.77
Synthesis and activity of new aryl- and heteroaryl-substituted pyrazole inhibitors of the transforming growth factor-beta type I receptor kinase domain. J Med Chem (2003) 1.72
Mechanisms of osteolytic bone metastases in breast carcinoma. Cancer (2003) 1.58
Transforming growth factor beta1 is associated with angiogenesis, metastasis, and poor clinical outcome in prostate cancer. Prostate (1998) 1.58
Circulating transforming growth factor beta 1 as a predictor of liver metastasis after resection in colorectal cancer. Clin Cancer Res (2001) 1.50
Ki26894, a novel transforming growth factor-beta type I receptor kinase inhibitor, inhibits in vitro invasion and in vivo bone metastasis of a human breast cancer cell line. Cancer Sci (2007) 1.45
Antitumor activity of a recombinant soluble betaglycan in human breast cancer xenograft. Cancer Res (2002) 1.31
Successful shape-based virtual screening: the discovery of a potent inhibitor of the type I TGFbeta receptor kinase (TbetaRI). Bioorg Med Chem Lett (2003) 1.27
Transforming growth factor-beta promotes survival of mammary carcinoma cells through induction of antiapoptotic transcription factor DEC1. Cancer Res (2007) 1.21
Transforming growth factor-beta signaling in prostate stromal cells supports prostate carcinoma growth by up-regulating stromal genes related to tissue remodeling. Cancer Res (2007) 1.19
Autocrine TGFbeta supports growth and survival of human breast cancer MDA-MB-231 cells. Oncogene (2002) 1.16
Elevated plasma levels of transforming growth factor-beta 1 (TGF-beta 1) in patients with advanced breast cancer: association with disease progression. Eur J Cancer (2003) 1.11
Effect of small-sized liposomal Adriamycin administered by various routes on a metastatic breast cancer model. Endocr Relat Cancer (2005) 1.03
Uncertain benefit from surgery in patients with lung metastases from breast carcinoma. Cancer (2004) 1.00
Expression of transforming growth factor beta type III receptor suppresses tumorigenicity of human breast cancer MDA-MB-231 cells. J Biol Chem (1997) 0.99
Tumor-suppressive and promoting function of transforming growth factor beta. Front Biosci (2004) 0.95
Transforming growth factor-beta 1 overexpression produces drug resistance in vivo: reversal by decorin. In Vivo (1998) 0.93
Plasma TGF-beta1-related survival of postmenopausal metastatic breast cancer patients. Clin Exp Metastasis (2004) 0.92
Weekly epirubicin plus docetaxel as first-line treatment in metastatic breast cancer. Br J Cancer (2007) 0.91
Transforming growth factor-beta and response to anticancer therapies in human liver and gastric tumors in vitro and in vivo. Int J Oncol (2000) 0.91
Mechanisms in the skeletal complications of breast cancer. Endocr Relat Cancer (2000) 0.90
Prostate carcinoma response to cytotoxic therapy: in vivo resistance. In Vivo (1998) 0.89
Abrogation of TGFbeta signaling induces apoptosis through the modulation of MAP kinase pathways in breast cancer cells. Exp Cell Res (2007) 0.84
[Analysis of indications and results of surgical treatment for patients with pulmonary metastasis]. Pneumonol Alergol Pol (1999) 0.81
Determination of transforming growth factor beta 1 mRNA expression in breast carcinomas by in situ hybridization. J Pathol (1995) 0.81
The immunoregulatory roles of transforming growth factor beta. Br J Biomed Sci (1995) 0.81
Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial. Lancet Oncol (2009) 9.39
Inhibition of PRC2 activity by a gain-of-function H3 mutation found in pediatric glioblastoma. Science (2013) 6.29
Cohesins localize with CTCF at the KSHV latency control region and at cellular c-myc and H19/Igf2 insulators. EMBO J (2008) 4.28
Rig-I-/- mice develop colitis associated with downregulation of G alpha i2. Cell Res (2007) 2.49
Identification of cell cycle-regulated genes in fission yeast. Mol Biol Cell (2004) 2.29
Tumor-induced anorexia and weight loss are mediated by the TGF-beta superfamily cytokine MIC-1. Nat Med (2007) 2.20
COP1-mediated ubiquitination of CONSTANS is implicated in cryptochrome regulation of flowering in Arabidopsis. Plant Cell (2008) 2.19
CD73 on tumor cells impairs antitumor T-cell responses: a novel mechanism of tumor-induced immune suppression. Cancer Res (2010) 2.13
Reputation-based partner choice promotes cooperation in social networks. Phys Rev E Stat Nonlin Soft Matter Phys (2008) 1.97
Caspase-1 contributes to Chlamydia trachomatis-induced upper urogenital tract inflammatory pathologies without affecting the course of infection. Infect Immun (2007) 1.85
Inhibition of pulmonary and skeletal metastasis by a transforming growth factor-beta type I receptor kinase inhibitor. Cancer Res (2006) 1.82
p27(Kip1) and cyclin E expression and breast cancer survival after treatment with adjuvant chemotherapy. J Natl Cancer Inst (2006) 1.74
Evolution of cooperation on stochastic dynamical networks. PLoS One (2010) 1.73
Imitation dynamics of vaccination behaviour on social networks. Proc Biol Sci (2010) 1.52
Enhanced susceptibility to urinary tract infection in the spinal cord-injured host with neurogenic bladder. Infect Immun (2013) 1.50
Mice deficient in MyD88 Develop a Th2-dominant response and severe pathology in the upper genital tract following Chlamydia muridarum infection. J Immunol (2010) 1.49
Dual role of SnoN in mammalian tumorigenesis. Mol Cell Biol (2006) 1.47
Vascular endothelial growth factor-C associated with computed tomography used in the diagnosis of lymph node metastasis of bladder carcinoma. Arch Med Res (2010) 1.45
Reuse of infected cardiac rhythm management devices in the same patients: a single-center experience. Pacing Clin Electrophysiol (2014) 1.40
Taoren-Honghua herb pair and its main components promoting blood circulation through influencing on hemorheology, plasma coagulation and platelet aggregation. J Ethnopharmacol (2011) 1.38
An unusual initial manifestation of metastatic papillary thyroid carcinoma: radioiodine uptake in lymph node metastatic lesions in a patient with Graves' disease. Endocr Pract (2002) 1.37
Myoepithelial cell staining patterns of papillary breast lesions: from intraductal papillomas to invasive papillary carcinomas. Am J Clin Pathol (2005) 1.36
A new algorithm for analysis of oligonucleotide arrays: application to expression profiling in mouse brain regions. J Mol Biol (2002) 1.33
Escalating association of Vibrio cholerae O139 with cholera outbreaks in India. J Clin Microbiol (2002) 1.33
Arcuate NPY controls sympathetic output and BAT function via a relay of tyrosine hydroxylase neurons in the PVN. Cell Metab (2013) 1.33
Kaposi's sarcoma-associated herpesvirus promotes angiogenesis by inducing angiopoietin-2 expression via AP-1 and Ets1. J Virol (2007) 1.32
Analysis of sentinel lymph node mapping with immediate pathologic review in patients receiving preoperative chemotherapy for breast carcinoma. Ann Surg Oncol (2002) 1.31
Prussian blue: a new framework of electrode materials for sodium batteries. Chem Commun (Camb) (2012) 1.31
Akt/cAMP-responsive element binding protein/cyclin D1 network: a novel target for prostate cancer inhibition in transgenic adenocarcinoma of mouse prostate model mediated by Nexrutine, a Phellodendron amurense bark extract. Clin Cancer Res (2007) 1.29
Disruption of palladin results in neural tube closure defects in mice. Mol Cell Neurosci (2005) 1.26
Transforming growth factor-beta suppresses the ability of Ski to inhibit tumor metastasis by inducing its degradation. Cancer Res (2008) 1.26
Maintenance of paternal methylation and repression of the imprinted H19 gene requires MBD3. PLoS Genet (2007) 1.24
Molecular profiling of endometrial malignancies. Obstet Gynecol Int (2010) 1.22
Extranuclear functions of ER impact invasive migration and metastasis by breast cancer cells. Cancer Res (2010) 1.20
Transforming growth factor-beta signaling in prostate stromal cells supports prostate carcinoma growth by up-regulating stromal genes related to tissue remodeling. Cancer Res (2007) 1.19
Three-dimensional graphene foam as a biocompatible and conductive scaffold for neural stem cells. Sci Rep (2013) 1.18
Evolution of in-group favoritism. Sci Rep (2012) 1.16
Therapeutic Electromagnetic Field (TEMF) and gamma irradiation on human breast cancer xenograft growth, angiogenesis and metastasis. Cancer Cell Int (2005) 1.16
Disruption of palladin leads to defects in definitive erythropoiesis by interfering with erythroblastic island formation in mouse fetal liver. Blood (2007) 1.15
An essential role for DNA methyltransferase 3a in melanoma tumorigenesis. Biochem Biophys Res Commun (2009) 1.15
Strategies for prevention of postoperative delirium: a systematic review and meta-analysis of randomized trials. Crit Care (2013) 1.15
Novel role of Y1 receptors in the coordinated regulation of bone and energy homeostasis. J Biol Chem (2007) 1.14
TGF-b superfamily cytokine MIC-1/GDF15 is a physiological appetite and body weight regulator. PLoS One (2013) 1.12
Macrophage inhibitory cytokine-1 (MIC-1/GDF15) and mortality in end-stage renal disease. Nephrol Dial Transplant (2011) 1.12
Macrophage inhibitory cytokine 1 (MIC-1/GDF15) decreases food intake, body weight and improves glucose tolerance in mice on normal & obesogenic diets. PLoS One (2012) 1.12
Three key residues underlie the differential affinity of the TGFbeta isoforms for the TGFbeta type II receptor. J Mol Biol (2005) 1.11
Minimally invasive stereotactic puncture and thrombolysis therapy improves long-term outcome after acute intracerebral hemorrhage. J Neurol (2011) 1.11
Endometrial effects of a tissue selective estrogen complex containing bazedoxifene/conjugated estrogens as a menopausal therapy. Fertil Steril (2009) 1.10
Palladin regulates cell and extracellular matrix interaction through maintaining normal actin cytoskeleton architecture and stabilizing beta1-integrin. J Cell Biochem (2007) 1.09
How small are small mutation rates? J Math Biol (2011) 1.08
Cellular senescence increases expression of bacterial ligands in the lungs and is positively correlated with increased susceptibility to pneumococcal pneumonia. Aging Cell (2011) 1.08
Universality of weak selection. Phys Rev E Stat Nonlin Soft Matter Phys (2010) 1.08
Assembly of TbetaRI:TbetaRII:TGFbeta ternary complex in vitro with receptor extracellular domains is cooperative and isoform-dependent. J Mol Biol (2005) 1.07
Emergence of social cooperation in threshold public goods games with collective risk. Phys Rev E Stat Nonlin Soft Matter Phys (2009) 1.07
Evolutionary dynamics on graphs: Efficient method for weak selection. Phys Rev E Stat Nonlin Soft Matter Phys (2009) 1.06
[Cell continuous extraction-HPLC determination biological affinity of 8 bufadienolides on MGC-803 cells and their correlation with anti-tumor activities]. Zhongguo Zhong Yao Za Zhi (2011) 1.06
Transforming growth factor-beta (TGF-beta)-inducible gene TMEPAI converts TGF-beta from a tumor suppressor to a tumor promoter in breast cancer. Cancer Res (2010) 1.06
Diabetic kidney disease in FVB/NJ Akita mice: temporal pattern of kidney injury and urinary nephrin excretion. PLoS One (2012) 1.06
Partner selections in public goods games with constant group size. Phys Rev E Stat Nonlin Soft Matter Phys (2009) 1.05
Coevolutionary dynamics of opinions and networks: from diversity to uniformity. Phys Rev E Stat Nonlin Soft Matter Phys (2008) 1.05
Great majority of recombination events in Arabidopsis are gene conversion events. Proc Natl Acad Sci U S A (2012) 1.05
Neuropeptide Y knockout mice reveal a central role of NPY in the coordination of bone mass to body weight. PLoS One (2009) 1.04
Promotion of cooperation induced by appropriate payoff aspirations in a small-world networked game. Phys Rev E Stat Nonlin Soft Matter Phys (2008) 1.02
Anorexia/cachexia of chronic diseases: a role for the TGF-β family cytokine MIC-1/GDF15. J Cachexia Sarcopenia Muscle (2012) 1.02
Positive margins following surgical resection of breast carcinoma: analysis of pathologic correlates. J Surg Oncol (2004) 1.02
Clinical array-based karyotyping of breast cancer with equivocal HER2 status resolves gene copy number and reveals chromosome 17 complexity. BMC Cancer (2010) 1.02
Systemic administration of a soluble betaglycan suppresses tumor growth, angiogenesis, and matrix metalloproteinase-9 expression in a human xenograft model of prostate cancer. Prostate (2005) 1.01
Partner switching stabilizes cooperation in coevolutionary prisoner's dilemma. Phys Rev E Stat Nonlin Soft Matter Phys (2009) 1.01
Nitric oxide synthase variants and disease-free survival among treated and untreated breast cancer patients in a Southwest Oncology Group clinical trial. Clin Cancer Res (2009) 1.01
A capture-sequencing strategy identifies IRF8, EBF1, and APRIL as novel IGH fusion partners in B-cell lymphoma. Blood (2013) 1.00
Calcineurin (CN) activation promotes apoptosis of glomerular podocytes both in vitro and in vivo. Mol Endocrinol (2011) 1.00
TGF-β signalling is mediated by two autonomously functioning TβRI:TβRII pairs. EMBO J (2011) 0.99
Penicillium kongii, a new terverticillate species isolated from plant leaves in China. Mycologia (2013) 0.99
Graphene-based nanosheets with a sandwich structure. Angew Chem Int Ed Engl (2010) 0.99
Evolution of cooperation driven by reputation-based migration. PLoS One (2012) 0.98
Blockade of transforming growth factor-beta (TGFβ) signaling inhibits osteoblastic tumorigenesis by a novel human prostate cancer cell line. Prostate (2011) 0.98
Biological activity evaluation and structure-activity relationships analysis of ferulic acid and caffeic acid derivatives for anticancer. Bioorg Med Chem Lett (2012) 0.98
A series of natural flavonoids as thrombin inhibitors: structure-activity relationships. Thromb Res (2010) 0.98
HER-2/neu expression as a predictor of response to neoadjuvant docetaxel in patients with operable breast carcinoma. Cancer (2005) 0.97
Involvement of FLIP in 2-methoxyestradiol-induced tumor regression in transgenic adenocarcinoma of mouse prostate model. Clin Cancer Res (2009) 0.97
Preparation of heteroduplex enhanced green fluorescent protein plasmid for in vivo mismatch repair activity assay. Anal Biochem (2009) 0.97
Functional imaging of interleukin 1 beta expression in inflammatory process using bioluminescence imaging in transgenic mice. BMC Immunol (2008) 0.97
Reduced expression of fumarate hydratase in clear cell renal cancer mediates HIF-2α accumulation and promotes migration and invasion. PLoS One (2011) 0.97
UPLC-QTOF-MS with chemical profiling approach for rapidly evaluating chemical consistency between traditional and dispensing granule decoctions of Tao-Hong-Si-Wu decoction. Chem Cent J (2012) 0.96
Ophiopogonin B-induced autophagy in non-small cell lung cancer cells via inhibition of the PI3K/Akt signaling pathway. Oncol Rep (2012) 0.96
Effects of heterogeneous wealth distribution on public cooperation with collective risk. Phys Rev E Stat Nonlin Soft Matter Phys (2010) 0.96
Necrostatin-1 suppresses autophagy and apoptosis in mice traumatic brain injury model. Neurochem Res (2012) 0.96